The study of antifungal and antibacterial action is of great interest and there are still many unknowns concerning the action of membrane lytic materials, and the way that drugs, and other benefit agents cross the cell membrane barrier. Fungal infections have been on the increase in the last 10 years and are becoming increasingly resistant to conventional therapies. Under this EU funded Marie Curie project we hope to boost understanding of the mode of action of membrane lytic materials at the molecular level using a simple proxy of fungal versus mammalian cell membranes.